PubMed

Low-dose naltrexone therapy improves active Crohn's disease.

Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.

Am J Gastroenterol. 2007 Apr;102(4):820-8. Epub 2007 Jan 11.PMID: 17222320 [PubMed - indexed for MEDLINE]Related articles

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

Lichtenstein GR, Yan S, Bala M, Hanauer S.

Am J Gastroenterol. 2004 Jan;99(1):91-6.PMID: 14687148 [PubMed - indexed for MEDLINE]Related articles

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.

Dig Liver Dis. 2004 May;36(5):342-7.PMID: 15191204 [PubMed - indexed for MEDLINE]Related articles

Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.

Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F.

Scand J Gastroenterol. 2006 Sep;41(9):1064-72.PMID: 16938720 [PubMed - indexed for MEDLINE]Related articles

Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice.

Cadahia V, García-Carbonero A, Vivas S, Fuentes D, Niño P, Rebollo P, Rodrigo L.

Rev Esp Enferm Dig. 2004 Jun;96(6):369-74; 374-8. English, Spanish. PMID: 15230666 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of infliximab maintenance therapy on health-related quality of life.

Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR.

Am J Gastroenterol. 2003 Oct;98(10):2232-8.PMID: 14572573 [PubMed - indexed for MEDLINE]Related articles

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.

Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, Weinstock JV.

Am J Gastroenterol. 2003 Sep;98(9):2034-41.PMID: 14499784 [PubMed - indexed for MEDLINE]Related articles

Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.

Hamann S, Sloan P.

J Opioid Manag. 2007 May-Jun;3(3):137-44.PMID: 18027539 [PubMed - indexed for MEDLINE]Related articles

Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study.

Peyrin-Biroulet L, Laclotte C, Bigard MA.

Aliment Pharmacol Ther. 2007 Mar 15;25(6):675-80.PMID: 17311600 [PubMed - indexed for MEDLINE]Related articlesFree article

Health-related quality of life during natalizumab maintenance therapy for Crohn's disease.

Feagan BG, Sandborn WJ, Hass S, Niecko T, White J.

Am J Gastroenterol. 2007 Dec;102(12):2737-46.PMID: 18042106 [PubMed - indexed for MEDLINE]Related articles

Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.

Yacyshyn BR, Barish C, Goff J, Dalke D, Gaspari M, Yu R, Tami J, Dorr FA, Sewell KL.

Aliment Pharmacol Ther. 2002 Oct;16(10):1761-70.PMID: 12269969 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.

Sands BE, Kozarek R, Spainhour J, Barish CF, Becker S, Goldberg L, Katz S, Goldblum R, Harrigan R, Hilton D, Hanauer SB.

Inflamm Bowel Dis. 2007 Jan;13(1):2-11.PMID: 17206633 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial.

Hinojosa J, Gomollón F, García S, Bastida G, Cabriada JL, Saro C, Ceballos D, Peñate M, Gassull MA; Spanish Scientific Group on Crohn's Disease and Ulcerative Colitis.

Aliment Pharmacol Ther. 2007 Feb 15;25(4):409-18.PMID: 17269996 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease.

Sands BE, Winston BD, Salzberg B, Safdi M, Barish C, Wruble L, Wilkins R, Shapiro M, Schwertschlag US; RHIL-11 Crohn's Study group.

Aliment Pharmacol Ther. 2002 Mar;16(3):399-406.PMID: 11876692 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB.

Gastroenterology. 2004 Feb;126(2):402-13.PMID: 14762776 [PubMed - indexed for MEDLINE]Related articles

Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.

Folwaczny C, Wiebecke B, Loeschke K.

Am J Gastroenterol. 1999 Jun;94(6):1551-5.PMID: 10364024 [PubMed - indexed for MEDLINE]Related articles

Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study.

Seiderer J, Brand S, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T.

Aliment Pharmacol Ther. 2007 Apr 1;25(7):787-96.PMID: 17373917 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease.

Abreu MT, Geller JL, Vasiliauskas EA, Kam LY, Vora P, Martyak LA, Yang H, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Adams JS, Targan SR.

J Clin Gastroenterol. 2006 Jan;40(1):55-63.PMID: 16340635 [PubMed - indexed for MEDLINE]Related articles

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.

Sandborn WJ, Hanauer S, Loftus EV Jr, Tremaine WJ, Kane S, Cohen R, Hanson K, Johnson T, Schmitt D, Jeche R.

Am J Gastroenterol. 2004 Oct;99(10):1984-9.PMID: 15447761 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany.

Witthöft T, Ludwig D.

Int J Colorectal Dis. 2005 Jan;20(1):18-23. Epub 2004 Sep 30.PMID: 15459773 [PubMed - indexed for MEDLINE]Related articles